155 related articles for article (PubMed ID: 8705857)
1. Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats.
Prakash S; Chang TM
Nat Med; 1996 Aug; 2(8):883-7. PubMed ID: 8705857
[TBL] [Abstract][Full Text] [Related]
2. Microencapsulated genetically engineered E. coli DH5 cells for plasma urea and ammonia removal based on: 1. Column bioreactor and 2. Oral administration in uremic rats.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):201-18. PubMed ID: 8773740
[TBL] [Abstract][Full Text] [Related]
3. Growth and survival of renal failure rats that received oral microencapsulated genetically engineered E. coli DH5 cells for urea removal.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1998 Jan; 26(1):35-51. PubMed ID: 9507755
[TBL] [Abstract][Full Text] [Related]
4. Oral microencapsulated live Saccharomyces cerevisiae cells for use in renal failure uremia: preparation and in vivo analysis.
Coussa R; Martoni C; Bhathena J; Urbanska AM; Prakash S
J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20798777
[TBL] [Abstract][Full Text] [Related]
5. Live E. coli cells to treat uremia.
Wrong O
Nat Med; 1997 Jan; 3(1):3; author reply 3-4. PubMed ID: 8986726
[No Abstract] [Full Text] [Related]
6. Artificial cells microencapsulated genetically engineered E. coli DH5 cells for the lowering of plasma creatinine in-vitro and in-vivo.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2000 Sep; 28(5):397-408. PubMed ID: 11009112
[TBL] [Abstract][Full Text] [Related]
7. Artificial cells with emphasis on cell encapsulation of genetically engineered cells.
Chang TM
Artif Organs; 1998 Nov; 22(11):958-65. PubMed ID: 9821530
[TBL] [Abstract][Full Text] [Related]
8. Genetically engineered E. coli cells containing K. aerogenes gene, microencapsulated in artificial cells for urea and ammonia removal.
Prakash S; Chang TM
Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):629-36. PubMed ID: 8117852
[TBL] [Abstract][Full Text] [Related]
9. Artificial cell microcapsules containing genetically engineered E. coli DH5 cells for in-vitro lowering of plasma potassium, phosphate, magnesium, sodium, chloride, uric acid, cholesterol, and creatinine: a preliminary report.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1999; 27(5-6):475-81. PubMed ID: 10595451
[TBL] [Abstract][Full Text] [Related]
10. Live E. coli cells to treat uremia.
Lange H
Nat Med; 1997 Jan; 3(1):2-3; author reply 3-4. PubMed ID: 8986725
[No Abstract] [Full Text] [Related]
11. Therapeutic uses of microencapsulated genetically engineered cells.
Chang TM; Prakash S
Mol Med Today; 1998 May; 4(5):221-7. PubMed ID: 9612802
[TBL] [Abstract][Full Text] [Related]
12. Preparation and in vitro analysis of microencapsulated genetically engineered E. coli DH5 cells for urea and ammonia removal.
Prakash S; Chang TM
Biotechnol Bioeng; 1995 Jun; 46(6):621-6. PubMed ID: 18623357
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells.
Prakash S; Chang TM
Int J Artif Organs; 2000 Jul; 23(7):429-35. PubMed ID: 10941635
[TBL] [Abstract][Full Text] [Related]
14. Microencapsulated Saccharomyces cerevisiae column bioreactor for potential use in renal failure uremia.
Coussa RG; Shah S; Jain P; Martoni C; Bhathena J; Malhotra M; Prakash S
Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):103-12. PubMed ID: 22288841
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro degradation of urea and uric acid by encapsulated genetically modified microorganisms.
O'Loughlin JA; Bruder JM; Lysaght MJ
Tissue Eng; 2004; 10(9-10):1446-55. PubMed ID: 15588404
[TBL] [Abstract][Full Text] [Related]
16. Growth kinetics of genetically engineered E. coli DH 5 cells in artificial cell APA membrane microcapsules: preliminary report.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1999 May; 27(3):291-301. PubMed ID: 10226691
[TBL] [Abstract][Full Text] [Related]
17. Free and microencapsulated Lactobacillus and effects of metabolic induction on urea removal.
Chow KM; Liu ZC; Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2003 Nov; 31(4):425-34. PubMed ID: 14672417
[TBL] [Abstract][Full Text] [Related]
18. Artificial cell biotechnology for medical applications.
Chang TM
Blood Purif; 2000; 18(2):91-6. PubMed ID: 10838466
[TBL] [Abstract][Full Text] [Related]
19. New method for preparing more stable microcapsules for the entrapment of genetically engineered cells.
Wang MY; Yu YT; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(3):257-69. PubMed ID: 16152691
[TBL] [Abstract][Full Text] [Related]
20. The potential of a microencapsulated urease-zeolite oral sorbent for the removal of urea in uremia.
Cattaneo MV; Chang TM
ASAIO Trans; 1991; 37(2):80-7. PubMed ID: 1649615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
